Aktionärsstruktur

Inhaber in %
Freefloat 94,27
Government Pension Fund - Global (The) 2,39
Vanguard Health Care Fund 1,83
Vanguard Total International Stock Index Fund 1,25
American Funds Income Fund of America 0,90
American Funds New Perspective Fund 0,85

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2016 2017 2018 2019 2020
Personal am Ende des Jahres 59.700 61.100 64.400 70.600 76.100
Umsatz pro Mitarbeiter in Mio. EUR 0,29 0,29 0,26 0,27 0,28

Bilanz (in Mio. EUR) - Aktiva

2016 2017 2018 2019 2020
Summe Umlaufvermögen 10.523 9.524 12.184 11.748 14.298
Summe Anlagevermögen 25.624 24.223 24.797 23.668 26.337
Summe Aktiva 50.602 46.833 47.622 46.331 48.816

Bilanz (in Mio. EUR) - Passiva

2016 2017 2018 2019 2020
Gesamtverschuldung/ -verbindlichkeiten 13.603 13.164 15.007 13.759 14.909
Summe Fremdkapital 37.112 34.531 36.595 35.313 37.376
Summe Eigenkapital 13.490 12.302 11.027 11.018 11.440
Summe Passiva 50.602 46.833 47.622 46.331 48.816

Adresse

Cambridge Biomedical Campus, CB2 0AA Cambridge
Telefon +44 (20) 3749-5000
Fax +44 (12) 2335-2858
Internet http://www.astrazeneca.com

Management

Adrian Charles Noel Kemp
Secretary
Colin Reisner
Head-Clinical Respiratory
David Fredrickson
Executive Vice President-Oncology Business Unit
Deborah DiSanzo
Independent Non-Executive Director
Diana Layfield
Non-Executive Director
Euan A. Ashley
Non-Executive Director
Hasan Jafri
Senior Medical Director
Helen MacPhee
Vice President
Henry D. Cremisi
Medical Director
Iskra Reic
Executive Vice President-Europe & Canada
Jeffrey Pott
Chief Human Resources Officer & General Counsel
Jonathan Thomas Charles Slade
Group Treasurer
Katarina Ageborg
Chief Compliance Officer & EVP-Sustainability
Kevin G. Lokay
Head-U.S. Immuno-oncology
Leif Valdemar Johansson
Non-Executive Chairman
Marc Pierre Jean Dunoyer
Chief Financial Officer & Executive Director
Marcus Wallenberg
Independent Non-Executive Director
Menelas N. Pangalos
EVP-Biopharmaceuticals Research & Development
Michel Demaré
Independent Non-Executive Director
Nazneen Rahman
Independent Non-Executive Director
Pam P. Cheng
Executive VP-Operations & Information Technology
Pascal Soriot
Chief Executive Officer & Executive Director
Philip Arthur John Broadley
Senior Independent Non-Executive Director
Ruud Dobber
Executive VP-Biopharmaceuticals Business
Sherilyn S. McCoy
Independent Non-Executive Director
Sjoerd Hubben
Vice President-Global Government Affairs & Policy
Thomas Kudsk Larsen
Investor Relations Contact
Tony Mok
Independent Non-Executive Director
Tyrell J. Rivers
Executive Director-Corporate Development